Diabetes rates skyrocket globally with millions left untreated

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million – over four times the total number in 1990, according to findings from a global analysis published ahead of World Diabetes Day in The Lancet.

Takeda and Protagonist sign rusfertide development deal

Share this article Rusfertide is a potential treatment for polycythemia vera, a chronic blood disorder. Credit: Siwakorn TH / Shutterstock.com. Takeda has entered a global

February 1, 2024

Opportunistic atrial fibrillation screening key to preventing strokes

People at risk should be tested for atrial fibrillation every time they attend a health appointment, according to results of the AFFECT-EU project, which is

March 18, 2024

Jacobio Pharma grants Allist rights to two assets in China

Jacobio Pharma chairman and CEO Dr Yinxiang Wang (right) and Jinxiang Du (left) at the agreement signing ceremony. Credit: JACOBIO PHARMACEUTICALS GROUP CO., LTD. Jacobio

September 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.